Nolen WA - Search Results

1

Rate of switch in bipolar patients prospectively treated with second-generation antidepressants as augmentation to mood stabilizers.

Post RM, Altshuler LL, Frye MA, Suppes T, Rush AJ, Keck PE Jr, McElroy SL, Denicoff KD, Leverich GS, Kupka R, Nolen WA. Post RM, et al. Among authors: nolen wa. Bipolar Disord. 2001 Oct;3(5):259-65. Bipolar Disord. 2001. PMID: 11912569 Clinical Trial.

2

Hypnotics as concurrent medication in depression. A placebo-controlled, double-blind comparison of flunitrazepam and lormetazepam in patients with major depression, treated with a (tri)cyclic antidepressant.

Nolen WA, Haffmans PM, Bouvy PF, Duivenvoorden HJ. Nolen WA, et al. J Affect Disord. 1993 Jul;28(3):179-88. doi: 10.1016/0165-0327(93)90103-q. J Affect Disord. 1993. PMID: 8104964 Clinical Trial.

3

Monoamine oxidase inhibitors in resistant major depression. A double-blind comparison of brofaromine and tranylcypromine in patients resistant to tricyclic antidepressants.

Nolen WA, Haffmans PM, Bouvy PF, Duivenvoorden HJ. Nolen WA, et al. J Affect Disord. 1993 Jul;28(3):189-97. doi: 10.1016/0165-0327(93)90104-r. J Affect Disord. 1993. PMID: 8408980 Clinical Trial.

4

Modification of the Clinical Global Impressions (CGI) Scale for use in bipolar illness (BP): the CGI-BP.

Spearing MK, Post RM, Leverich GS, Brandt D, Nolen W. Spearing MK, et al. Psychiatry Res. 1997 Dec 5;73(3):159-71. doi: 10.1016/s0165-1781(97)00123-6. Psychiatry Res. 1997. PMID: 9481807 Clinical Trial.

5

Olanzapine in treatment-resistant bipolar disorder.

McElroy SL, Frye M, Denicoff K, Altshuler L, Nolen W, Kupka R, Suppes T, Keck PE Jr, Leverich GS, Kmetz GF, Post RM. McElroy SL, et al. J Affect Disord. 1998 May;49(2):119-22. doi: 10.1016/s0165-0327(98)00002-0. J Affect Disord. 1998. PMID: 9609675 Clinical Trial.

6

Lamotrigine for the treatment of bipolar disorder: a clinical case series.

Suppes T, Brown ES, McElroy SL, Keck PE Jr, Nolen W, Kupka R, Frye M, Denicoff KD, Altshuler L, Leverich GS, Post RM. Suppes T, et al. J Affect Disord. 1999 Apr;53(1):95-8. doi: 10.1016/s0165-0327(98)00077-9. J Affect Disord. 1999. PMID: 10363672 Clinical Trial.

7

[Risk of inducing resistance upon stopping and restarting lithium after long-term usage].

Oostervink F, Nolen WA, Hoenderboom AC, Kupka RW. Oostervink F, et al. Among authors: nolen wa. Ned Tijdschr Geneeskd. 2000 Feb 26;144(9):401-4. Ned Tijdschr Geneeskd. 2000. PMID: 10719540 Review. Dutch.

8

Open-label adjunctive topiramate in the treatment of bipolar disorders.

McElroy SL, Suppes T, Keck PE, Frye MA, Denicoff KD, Altshuler LL, Brown ES, Nolen WA, Kupka RW, Rochussen J, Leverich GS, Post RM. McElroy SL, et al. Among authors: nolen wa. Biol Psychiatry. 2000 Jun 15;47(12):1025-33. doi: 10.1016/s0006-3223(99)00316-9. Biol Psychiatry. 2000. PMID: 10862801 Clinical Trial.

9

Methodological issues in developing new acute treatments for patients with bipolar illness.

Rush AJ, Post RM, Nolen WA, Keck PE Jr, Suppes T, Altshuler L, McElroy SL. Rush AJ, et al. Among authors: nolen wa. Biol Psychiatry. 2000 Sep 15;48(6):615-24. doi: 10.1016/s0006-3223(00)00898-2. Biol Psychiatry. 2000. PMID: 11018232 Review.

10

Validation of the prospective NIMH-Life-Chart Method (NIMH-LCM-p) for longitudinal assessment of bipolar illness.

Denicoff KD, Leverich GS, Nolen WA, Rush AJ, McElroy SL, Keck PE, Suppes T, Altshuler LL, Kupka R, Frye MA, Hatef J, Brotman MA, Post RM. Denicoff KD, et al. Among authors: nolen wa. Psychol Med. 2000 Nov;30(6):1391-7. doi: 10.1017/s0033291799002810. Psychol Med. 2000. PMID: 11097079

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

402 results

Search Page

Filters